A forward-thinking technology company in Wales developing the world’s first non-invasive wearable blood glucose monitor has been recognised at a national level for its contribution to advancing diabet...
A Leicester doctor whose “constant curiosity” propelled her rise to be among the world’s leading type 2 diabetes and obesity experts has been named a Dame in The King’s Birthday Honours List. Professo...
Healthcare professionals involved in initiating or supporting people using continuous glucose monitoring (CGM) are invited to share their views in a short survey exploring the support people living wi...
A trio of pioneering review papers published in The Lancet that offer fresh perspectives on cardiometabolic multiple long-term conditions (MLTCs or multimorbidity) has been unveiled on the internation...
A statement from the organisers: We anticipate that we will receive sponsorship from pharmaceutical companies for this event. As soon as sponsorship is confirmed, the details will be added to this pa...
Children and young people with type 1 diabetes who start using automated insulin delivery systems within six months of diagnosis are likely to have better glycaemic control than those who delay using ...
The programme for an international diabetic neuropathy event has been unveiled, with sessions set to cover a range of topics including disease-modifying agents, pain treatment and transcriptomics. NEU...
Young adults across the UK living with type 1 diabetes are still able to take part in a research study exploring experiences of moving from paediatric to adult diabetes services. The study is being le...
Hybrid closed-loop insulin pump systems have yielded drastic improvements in controlling high blood glucose levels after being rolled out to tens of thousands of people with type 1 diabetes over the l...